Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.
|Title||Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.|
|Publication Type||Journal Article|
|Year of Publication||2015|
|Authors||Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, D Collins L|
|Corporate Authors||Alzheimer's Disease Neuroimaging Initiative|
|Volume||36 Suppl 1|
|Date Published||2015 Jan|
|Keywords||Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Biomarkers, Cohort Studies, Diffusion Magnetic Resonance Imaging, Disease Progression, Female, Forecasting, Gray Matter, Hippocampus, Humans, Male, Neocortex, Neuroimaging, Sensitivity and Specificity|
Optimized magnetic resonance imaging (MRI)-based biomarkers of Alzheimer's disease (AD) may allow earlier detection and refined prediction of the disease. In addition, they could serve as valuable tools when designing therapeutic studies of individuals at risk of AD. In this study, we combine (1) a novel method for grading medial temporal lobe structures with (2) robust cortical thickness measurements to predict AD among subjects with mild cognitive impairment (MCI) from a single T1-weighted MRI scan. Using AD and cognitively normal individuals, we generate a set of features potentially discriminating between MCI subjects who convert to AD and those who remain stable over a period of 3 years. Using mutual information-based feature selection, we identify 5 key features optimizing the classification of MCI converters. These features are the left and right hippocampi gradings and cortical thicknesses of the left precuneus, left superior temporal sulcus, and right anterior part of the parahippocampal gyrus. We show that these features are highly stable in cross-validation and enable a prediction accuracy of 72% using a simple linear discriminant classifier, the highest prediction accuracy obtained on the baseline Alzheimer's Disease Neuroimaging Initiative first phase cohort to date. The proposed structural features are consistent with Braak stages and previously reported atrophic patterns in AD and are easy to transfer to new cohorts and to clinical practice.
|Alternate Journal||Neurobiol. Aging|
|Grant List||MOP-111169 / / Canadian Institutes of Health Research / Canada |
U01 AG024904 / AG / NIA NIH HHS / United States